Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://hassanhflj976846.bloggactif.com/37580778/retatrutide-a-promising-new-treatment-for-obesity